Myopia & Presbyopia Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Myopia & Presbyopia Treatment Market, Myopia Treatment Type

7.1.  Myopia & Presbyopia Treatment Market, Myopia Treatment Type, 2021-2028

7.1.1.    Corrective

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Surgical

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Drugs

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Myopia & Presbyopia Treatment Market, Presbyopia Treatment Type

8.1.  Myopia & Presbyopia Treatment Market, Presbyopia Treatment Type, 2021-2028

8.1.1.    Prescription Lenses

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Contact Lenses

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Intraocular Lenses

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Refractive Surgery

8.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Myopia & Presbyopia Treatment Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.1.2.    Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.1.3.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.1.4.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.2.2.    Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.2.3.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.2.4.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.2.5.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.2.6.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.3.2.    Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.3.3.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.3.4.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.3.5.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.3.6.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.4.2.    Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.4.3.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.4.4.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.4.5.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.4.6.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.5.2.    Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.5.3.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, Myopia Treatment Type (2016-2028)

9.5.4.2.        Market Revenue and Forecast, Presbyopia Treatment Type (2016-2028)

Chapter 10.  Company Profiles

10.1.              Ziemer Ophthalmic Systems AG

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              NIDEK CO., LTD.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Johnson & Johnson Vision

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Essilor Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Zeiss International

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              ALCON VISION LLC

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Bausch & Lomb Incorporated

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Haag-Streit UK

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Topcon Corporation

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms